| pubmed-article:19324976 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0238598 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0005938 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C1837352 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
| pubmed-article:19324976 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:19324976 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19324976 | pubmed:dateCreated | 2009-5-12 | lld:pubmed |
| pubmed-article:19324976 | pubmed:abstractText | Discontinuation of growth hormone (GH) therapy on completion of linear growth may adversely affect bone mineral density (BMD) in young adults with childhood-onset GH-deficiency (GHD). In the present study, we analyzed the impact of GH treatment on bone in young adults with GHD. | lld:pubmed |
| pubmed-article:19324976 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19324976 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19324976 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19324976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19324976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19324976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19324976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19324976 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19324976 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19324976 | pubmed:issn | 1479-683X | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:KellerAA | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:TauberMM | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:ChansonPP | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:RaczKK | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:ConwayG SGS | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:Szarras-Czapn... | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:ZacharisHH | lld:pubmed |
| pubmed-article:19324976 | pubmed:author | pubmed-author:1369 GHD to... | lld:pubmed |
| pubmed-article:19324976 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19324976 | pubmed:volume | 160 | lld:pubmed |
| pubmed-article:19324976 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19324976 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19324976 | pubmed:pagination | 899-907 | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:meshHeading | pubmed-meshheading:19324976... | lld:pubmed |
| pubmed-article:19324976 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19324976 | pubmed:articleTitle | Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. | lld:pubmed |
| pubmed-article:19324976 | pubmed:affiliation | Department of Endocrinology and Diabetes, University College London Hospitals, 250 Euston Road, London NW1 2PQ, UK. g.conway@ucl.ac.uk | lld:pubmed |
| pubmed-article:19324976 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19324976 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19324976 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
